Over 167 lakh doses of the COVID-19 vaccine have been supplied to 20 countries till February 9, Minister of State for Health Ashwini Choubey informed the Lok Sabha on Friday and asserted that external supplies of the vaccine are being undertaken with due regard to domestic production and adequate availability for the national vaccination programme.
"Supplies have been made of 167.7 lakh doses to 20 countries until 9 February 2021. This includes gift of 62.7 lakh doses to 13 countries and commercial procurement of 105 lakh doses by eight countries," Choubey said in a written reply.
India is a member of COVAX facility (created by Gavi Global Alliance for Vaccines & Immunization, CEPI Coalition for Epidemic Preparedness Innovations and WHO World Health Organisation) and is both a recipient of vaccines from the facility as well as a supplier of vaccines.
In addition to COVAX facility, external supplies have been made bilaterally through gifts by the Government of India and commercial sales by the manufacturers.
On whether the supply of vaccines to other countries will have any adverse effect on controlling the disease in the country, Choubey said, "External supplies are being undertaken with due regard to domestic production and adequate availability for the national vaccination programme.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)